Kaplan‐Meier estimates of first PFS (A), second PFS (B), and overall survival (C) in patients who received trifluridine/tipiracil followed by regorafenib (continuous line) or the reverse sequence (dashed line).
Abbreviations: CI, confidence interval; HR, hazard ratio; PFS, progression‐free survival.